Pfizer Inc is planning to acquire India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd, for a possible price of $2 bn, according to reports.
Reports stated that the deal could be reached this quarter.
Agila makes cancer treatments and antibiotics.
- Expectation, Highlights and Live Updates on Budget 2016.
- Get the most detailed result analysis on the web - Real Fast!
- Actionable & Award-Winning Research on 500 Listed Indian Companies.